about
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cellsThe crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolutionThe BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivityRoles of platelet factor 4 in hematopoiesis and angiogenesisAntibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cellsAtomic description of the immune complex involved in heparin-induced thrombocytopeniaPlatelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission.Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia.Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia.Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4.Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.Structural diversity of heparan sulfate binding domains in chemokinesPlatelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombinOral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.Heparin-protein interactions.Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1.Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain.Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.Aggregation-independent modulation of proteoglycan binding by neutralization of C-terminal acidic residues in the chemokine macrophage inflammatory protein 1alpha.Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.13C-NMR relation study of heparin-disaccharide interactions with tripeptides GRG and GKG.So you think computational approaches to understanding glycosaminoglycan-protein interactions are too dry and too rigid? Think again!
P2860
Q24323257-BF090605-943F-445F-BE34-7DFB8368E8AEQ27729945-06631DD2-4711-4C25-8EC1-979792FBC030Q28140341-F223FEE2-6C8F-4E52-AE33-924EF0BDAF48Q28294538-DD7D88DE-F953-427F-AD6D-D675C556F760Q28378442-EFD7A732-7A9A-46F6-A94A-C51DB84D689CQ30665349-386FFEBC-09C8-414E-A79F-1C178B13B751Q30838366-25E8E519-B9B4-4B46-BED7-8EBD38EED750Q33329858-E50E903B-BD8F-4FC0-A15B-11926D8A5299Q33400431-83B8D9AD-CB59-4315-9D0C-ED0B005DA8B3Q33407740-B90813ED-1367-4D32-B089-FAF643B6A9A0Q33430677-8CFBFA20-77B9-48E0-9D4E-5FFFB13F6BDDQ33502479-E9017F42-F2D6-4586-A82C-D554421E9B34Q34008721-D70F8062-762C-4466-8C56-76E2C660ABFBQ34452632-8B6624C9-6918-4A11-9EDD-128C80274DE2Q34756881-2B1E0331-612D-4BDB-8882-6FB7C10AA178Q35030190-2048CEA1-2735-4F53-8EA9-53111B32ACC8Q35913867-AF7175BD-8B0F-46DA-97B9-DF6C4F8629A7Q38339095-5D9BE56A-D93F-4525-8C53-DED2486A04BDQ38350708-21688289-AC2F-4D26-94FD-1477DA7B10E2Q41812470-686BC826-91EB-4A97-A2FB-0A9D1BDF5CAAQ42002922-38668E12-F526-4A8A-95C4-2B72D8324E4BQ42012051-9FC1E299-5E45-48CC-854B-B718B58EE064Q42412940-FA99399F-393B-4786-A668-1FB39B1E01E9Q42981760-E7998A4C-FEE2-4F6C-8919-C7071BEDC73FQ50065075-843852F8-B094-430C-A16E-274046754488
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
A model of the platelet factor 4 complex with heparin.
@en
type
label
A model of the platelet factor 4 complex with heparin.
@en
prefLabel
A model of the platelet factor 4 complex with heparin.
@en
P2093
P2860
P356
P1433
P1476
A model of the platelet factor 4 complex with heparin.
@en
P2093
Edwards BF
St Charles R
Stuckey JA
P2860
P304
P356
10.1002/PROT.340140213
P407
P577
1992-10-01T00:00:00Z